Liberty Health Sciences (OTCMKTS:LHSIF) Stock Price Down 2.2% – Here’s Why

Liberty Health Sciences Inc. (OTCMKTS:LHSIF – Get Free Report) shares dropped 2.2% during trading on Tuesday. The company traded as low as $1.10 and last traded at $1.1446. 671,400 shares changed hands during mid-day trading, a decline of 60% from the average session volume of 1,668,884 shares. The stock had previously closed at $1.17.

Liberty Health Sciences Trading Down 2.2%

The company has a market capitalization of $392.01 million, a price-to-earnings ratio of 38.17 and a beta of 1.70. The company has a 50 day moving average price of $1.14 and a 200 day moving average price of $1.14.

About Liberty Health Sciences

(Get Free Report)

Liberty Health Sciences Inc was a Canadian cannabis company focused on cultivating, processing, and dispensing medical cannabis in the United States. Its operations were concentrated in Florida, where the company served registered medical marijuana patients through a network of dispensaries and related cannabis products.

The company’s activities included the production of cannabis flower, oils, capsules, concentrates, and other medical cannabis formulations. Liberty marketed products under its own brand and operated retail locations designed to provide patients with medical cannabis products and educational support.

Liberty Health Sciences was acquired by AYR Wellness Inc in 2021 and subsequently became part of AYR’s Florida operations.

See Also

Receive News & Ratings for Liberty Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.